StonvexLoading…
StonvexStonvexStonvexCore line items from IBTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $82.48M | $342.39M | $253.86M | $170.60M |
Operating Income | $-10.83M | $-841.00K | $801.00K | $-1.56M |
Net Income | $-10.32M | $3.58M | $4.58M | $2.49M |
EPS (Diluted) | $-0.43 | $0.12 | $0.15 | $0.10 |
Total Assets | $479.92M | $525.91M | $569.43M | $600.78M |
Total Liabilities | $230.94M | $238.26M | $239.82M | $246.65M |
Cash & Equivalents | $164.60M | $186.61M | $223.30M | $250.55M |
Free Cash Flow OCF − CapEx | $27.31M | $74.98M | $54.70M | $40.20M |
Shares Outstanding | 24.15M | 30.10M | 31.00M | 31.82M |